ENTA

Enanta Pharmaceuticals, Inc. - Common Stock (ENTA)

About Enanta Pharmaceuticals, Inc. - Common Stock (ENTA)

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Details

Daily high

$13.51

Daily low

$13.09

Price at open

$13.50

52 Week High

$17.15

52 Week Low

$7.05

Market cap

393.2M

Dividend yield

Volume

192,951

Avg. volume

234,121

P/E ratio

-5.60

Enanta Pharmaceuticals, Inc. - Common Stock News